Keywords: Novartis, Apotex, Patent dispure, Patanol, Ph III trialk, Canakinumab, ACZ885, Gouty arthritis, Kyowa Hakko

Novartis wins in Apotex patent case; gout drug ACZ885 reduced risk of new attacks by up to 68% vs steroid

Article | 26 May 2011

Print This

Swiss drug major Novartis (NOVN: VX) says that that two affiliates of its Alcon Division have prevailed in a US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in